Blossoms-Sai Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.67 M
as on 17-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
as on 17-11-2024
- Revenue %
(FY 2023)
- Profit -15094.77%
(FY 2023)
- Ebitda -18990.63%
(FY 2023)
- Net Worth -30.10%
(FY 2023)
- Total Assets 159.12%
(FY 2023)
About Blossoms-Sai Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.67 M.
The company currently has active open charges totaling ₹3.50 Cr.
Vijay Kurukuri, Sandeep Tammareddy, and Venkata Kunla serve as directors at the Company.
- CIN/LLPIN
U85110AP2021PTC117636
- Company No.
117636
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blossoms-Sai Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Kurukuri  | Director | 13-Apr-2021 | Current |
Sandeep Tammareddy  | Director | 10-Mar-2021 | Current |
| Venkata Kunla | Director | 10-Mar-2021 | Current |
Financial Performance of Blossoms-Sai Healthcare.
Blossoms-Sai Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 15094.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blossoms-Sai Healthcare?
In 2023, Blossoms-Sai Healthcare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Blossoms Research Center And Healthcare Guntur LlpActive 7 years 7 months
Sandeep Tammareddy is a mutual person
- Blossoms Research Center And Healthcare Eluru LlpActive 1 year 7 months
Sandeep Tammareddy and Venkata Kunla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 24 Feb 2023 | ₹3.50 Cr | Open |
How Many Employees Work at Blossoms-Sai Healthcare?
Blossoms-Sai Healthcare has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blossoms-Sai Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blossoms-Sai Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
